Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
Abstract The application of patient-derived xenografts (PDX) in drug screening and testing is a costly and time-consuming endeavor. While cell lines permit extensive mechanistic studies, many human breast cancer cell lines lack patient characteristics and clinical treatment information. Establishing...
Guardado en:
Autores principales: | Yongxian Zhuang, Jordan M. Grainger, Peter T. Vedell, Jia Yu, Ann M. Moyer, Huanyao Gao, Xiao-Yang Fan, Sisi Qin, Duan Liu, Krishna R. Kalari, Matthew P. Goetz, Judy C. Boughey, Richard M. Weinshilboum, Liewei Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0faaa823e1d474ca427db78a9f24251 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes
por: Duan Liu, et al.
Publicado: (2017) -
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting
por: Ann L. Oberg, et al.
Publicado: (2021) -
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
por: Kuan-lin Huang, et al.
Publicado: (2017) -
Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer.
por: Bruna Victorasso Jardim-Perassi, et al.
Publicado: (2014) -
Correction: Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
por: Kuan-lin Huang, et al.
Publicado: (2017)